Alpha Cognition Inc. SEC filings ACOG
Alpha Cognition Inc. has 216 filings in SEC EDGAR's recent list, going back to Oct 16, 2015. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jun 23, 2026 (officer or director change, shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Aug 29, 2025 | — |
| CORRESP | Letter to the SEC | Aug 28, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 28, 2025 | — |
| EFFECT | Filing | Jul 25, 2025 | — |
| CORRESP | Letter to the SEC | Jul 23, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 23, 2025 | — |
| EFFECT | Filing | Jul 8, 2025 | — |
| CORRESP | Letter to the SEC | Jul 3, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 3, 2025 | — |
| EFFECT | Filing | Jan 13, 2025 | — |
| EFFECT | Filing | Jan 13, 2025 | — |
| CORRESP | Letter to the SEC | Jan 10, 2025 | — |
| CORRESP | Letter to the SEC | Jan 10, 2025 | — |
| UPLOAD | Letter from the SEC | Jan 3, 2025 | — |
| D | Filing | Nov 18, 2024 | — |
| CERT | Filing | Nov 12, 2024 | — |
| POS EX | Post-effective amendment | Nov 12, 2024 | — |
| EFFECT | Filing | Nov 8, 2024 | — |
| 8-A12B | For registration of certain classes | Nov 8, 2024 | — |
| CORRESP | Letter to the SEC | Nov 6, 2024 | — |
| CORRESP | Letter to the SEC | Nov 6, 2024 | — |
| CORRESP | Letter to the SEC | Oct 25, 2024 | — |
| EFFECT | Filing | Oct 23, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 23, 2024 | — |
| CORRESP | Letter to the SEC | Oct 21, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 21, 2024 | — |
| D | Filing | Oct 9, 2024 | — |
| EFFECT | Filing | Jun 7, 2024 | — |
| CORRESP | Letter to the SEC | Jun 6, 2024 | — |
| DRS | Filing | Jun 4, 2024 | — |
| CORRESP | Letter to the SEC | May 22, 2024 | — |
| UPLOAD | Letter from the SEC | May 21, 2024 | — |
| CORRESP | Letter to the SEC | May 10, 2024 | — |
| UPLOAD | Letter from the SEC | May 8, 2024 | — |
| DRSLTR | Filing | Apr 23, 2024 | — |
| DRS/A | Filing | Apr 23, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 17, 2024 | — |
| DRS/A | Filing | Mar 21, 2024 | — |
| DRS | Filing | Feb 9, 2024 | — |
| D | Filing | Jan 31, 2024 | — |
| D | Filing | Jan 5, 2024 | — |
| D | Filing | Nov 20, 2023 | — |
| D | Filing | Oct 19, 2023 | — |
| D | Filing | Sep 12, 2023 | — |
| D | Filing | Mar 28, 2023 | — |
| D | Filing | Feb 28, 2023 | — |
| D | Filing | Oct 18, 2021 | — |
| D | Filing | Dec 28, 2020 | — |
| D | Filing | May 1, 2020 | — |
| D | Filing | Oct 9, 2019 | — |
| D | Filing | Jul 20, 2018 | — |
| D | Filing | Dec 19, 2017 | — |
| D | Filing | Apr 26, 2016 | — |
| D | Filing | Oct 16, 2015 | — |
Showing 54 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- ACOG (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Grapevine, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1655923
- Former names
- Neurodyn Cognition Inc. (until Oct 9, 2019)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.